1h-tetrazole has been researched along with losartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno, C; Carocci, A; Catalano, A; Di Mola, A; Franchini, C; Vanderheyden, PM | 1 |
| Arksey, N; Beanlands, RS; DaSilva, JN; deKemp, RA; Hachem, M; Hadizad, T; Ismail, B; Valdivia, AC | 1 |
2 other study(ies) available for 1h-tetrazole and losartan
| Article | Year |
|---|---|
1-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-pyrrolidine-2-carboxamide: investigation of structural variations.
Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; CHO Cells; Cricetinae; Humans; Ligands; Losartan; Molecular Structure; Protein Binding; Pyrrolidines; Receptor, Angiotensin, Type 1; Tetrazoles | 2011 |
Synthesis and evaluation of the novel 2-[¹⁸F]fluoro-3-propoxy-triazole-pyridine-substituted losartan for imaging AT₁ receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Fluorine Radioisotopes; Kidney; Losartan; Male; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles | 2014 |